Skip to content

Today's Technology For Tomorrow's Kidney Care

Intestinal Dialysis™     A Break Through technology

In transition from Kidney health supplement to a live biotherapeutic product (LBP) development under CBER/USFD approved Investigational New Drug(IND) for multisite RCT, CKD patients (N=630).For more details refer to Clinical Trials. 

Intestinal Dialysis™ (a.k.a Enteric Dialysis®) – Modulating the Gut Microbiome with Probiotics and Prebiotics (Gut-Kidney Connection)

Kibow's - Intestinal Dialysis™Award winning and patented technology

2020 Business of the Year

Delaware County Chamber of Commerce

Bio - Biotechnology Innovation Organization

2005 - Innovation Corridor Abstract Winner, Boston, MA

2018 - Invited Company for Presentation, Boston, MA

Kibow Buzz of Bio Winner (Kidney Health)

2014 - A “Buzz of Bio" Winner

Pipelines of Promise category, International Bio conference, San Diego, CA

The first dietary supplement Company nominated to participate in the "Buzz of Bio".

2019 - Dun & Bradstreet Award

In recognition of unwavering commitment to business growth

Supported by Visionary & Distinguished Nephrologists and Scientists

“WILL THE BOWEL BE THE KIDNEY OF THE FUTURE”

SYMPOSIUM AT THE INTERNATIONAL SOCIETY OF ARTIFICIAL INTERNAL ORGANS IN EDINBURGH, SCOTLAND. Aug 04, 1999

Utenim ad minim eniami quis nostrud exer.

Utenim ad minim eniami quis nostrud exer.

Utenim ad minim eniami quis nostrud exer.

Utenim ad minim eniami quis nostrud exer.

Subscribe Newsletter &Get Company News